Please login to the form below

Not currently logged in
Email:
Password:

STS

This page shows the latest STS news and features for those working in and with pharma, biotech and healthcare.

EC approves Novartis’ Kymriah for advanced blood cancer

EC approves Novartis’ Kymriah for advanced blood cancer

decreasing benefit,” said Catherine Thieblemont, head of the haemato-oncology unit of St-Louis Hospital.

Latest news

More from news
Approximately 2 fully matching, plus 150 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 291 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....